Comparative Study of the NIDEK TONOREF III with Predicate Devices

March 6, 2025 updated by: Nidek Co. LTD.

Comparative Study of the NIDEK TONOREF III with the Haag-Streit, Perkins Hand-held Applanation Tonometer for Tonometry Function and NIDEK TONOREF III with the NIDEK CEM-530 for Pachymetry Function

The primary objective of this clinical study is to prove that tonometry values for NIDEK TONOREF III are comparable to the predicate device and to prove that the pachymeter function of NIDEK TONOREF III is equivalent to the predicate device. The secondary objective is to demonstrate that the test device is as safe as the predicate devices.

Study Overview

Study Type

Interventional

Enrollment (Actual)

183

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Birmingham, United Kingdom, B4 7ET, UK
        • Aston University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Exclusion criteria

  1. Subjects with only one functional eye;
  2. Those with one eye having poor or eccentric fixation;
  3. Those with corneal scarring or who have had corneal surgery including corneal laser surgery;
  4. Microphthalmos;
  5. Buphthalmos;
  6. Contact lens wearers;
  7. Dry eyes;
  8. Lid squeezers - blepharospasm;
  9. Nystagmus;
  10. Keratoconus;
  11. Any other corneal or conjunctival pathology or infection.
  12. central corneal thickness greater than 0,600 mm or less than 0,500 mm (2 standard deviations about the human mean)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Adults 18 years old or older
NIDEK TONOREFIII
Nidek CEM-530 is a non-contact ophthalmic microscope, optical pachymeter, and camera used for examination of the corneal endothelium and for measurement of the thickness of the cornea.
The auto ref/kerato/tono/pachymeter TONOREF III is a medical device which measures objective refractive errors, corneal curvature radius, intraocular pressure and corneal thickness of the patient's eye.
Haag-Streit Goldmann Manual Tonometer measures intraocular pressure to aid in the screening and diagnosis of glaucoma

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Equivalent to legally-marketed devices
Time Frame: One or two study visits per subject. One visit is less than two hours.
Agreement of intraocular pressure (mmHg) measurement for TONOREFIII and PAT
One or two study visits per subject. One visit is less than two hours.
Equivalent to the pachymeter function
Time Frame: One or two study visits per subject. One visit is less than two hours.
Agreement of central corneal thickness (µm) measurement for TONOREF III and CEM-530
One or two study visits per subject. One visit is less than two hours.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The numbers of adverse events
Time Frame: One or two study visits per subject. One visit is less than two hours.
To demonstrate that the test device is as safe as the predicate devices.
One or two study visits per subject. One visit is less than two hours.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Director: Tadakazu Ichimura, Nidek Co. LTD.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 27, 2024

Primary Completion (Actual)

December 13, 2024

Study Completion (Actual)

December 13, 2024

Study Registration Dates

First Submitted

March 24, 2024

First Submitted That Met QC Criteria

April 9, 2024

First Posted (Actual)

April 12, 2024

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

March 6, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • NIDEK-TONOREF-UK-0001

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Intraocular Pressure

Clinical Trials on NIDEK CEM-530

Subscribe